Home › Diffuse Scleroderma › Iowa › Cedar Rapids
Diffuse Scleroderma clinical trials in Cedar Rapids, IA
3 studies for Diffuse Scleroderma are looking for participants at sites in and around Cedar Rapids (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RecruitingPhase 1
- University of Iowa, Iowa City · 25 mi away
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
RecruitingPhase 1
- University of Iowa, Iowa City · 25 mi away
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
- Artiva Investigational Site Iowa, Iowa City · 25 mi away
Diffuse Scleroderma trials in other cities
- New York City, NY8 studies
- Ann Arbor, MI7 studies
- Chicago, IL7 studies
- Durham, NC6 studies
- Los Angeles, CA6 studies
- Boston, MA5 studies
- Houston, TX5 studies
- Baltimore, MD5 studies
- New Orleans, LA4 studies
- Kansas City, KS4 studies
- Philadelphia, PA4 studies
- Pittsburgh, PA4 studies
Other studies in Cedar Rapids
- Non-Small Cell Lung Cancer20 studies
- Breast Cancer17 studies
- Cancer (all types)16 studies
- Acute Myeloid Leukemia16 studies
- Multiple Myeloma15 studies
- Lung Cancer14 studies
- Colorectal Cancer13 studies
- Prostate Cancer12 studies
- Head and Neck Squamous Cell Carcinoma12 studies
- Melanoma10 studies
- Stroke10 studies
- Endometrial Cancer10 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.